when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

8,127 products tracked · 323 matching

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health

Preclinical
Therapeutic Inducers of NK cell Killing (ThINKK)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Centre Hospitalier Universitaire Sainte-Justine
Preclinical
TumoG
Glioblastoma Multiforme (GBM) IntraGel Therapeutics Ltd
Preclinical
TumoL
Lung Cancer IntraGel Therapeutics Ltd
Preclinical

page 10 of 11

131

Solid Tumor

$FATE FATE THERAPEUTICS INC

Preclinical

Glioblastoma Multiforme (GBM) Up Therapeutics LLC

Preclinical

Melanoma Trekka Therapeutics LLC

Preclinical

Solid Tumor VerImmune Inc

Preclinical

Basal Cell Carcinoma (Basal Cell Epithelioma) ArrayPatch Ltd

Preclinical

Triple-Negative Breast Cancer (TNBC) Isoprene Pharmaceuticals Inc

Preclinical

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Vitruviae LLC

Preclinical

Refractory Multiple Myeloma$NVS NOVARTIS AG

Preclinical

Human Papillomavirus (HPV) Associated Cancer$VXRT Vaxart, Inc.

Preclinical

Vaccine for Triple-Negative Breast Cancer

Triple-Negative Breast Cancer (TNBC) Flow Pharma Inc

Preclinical

Vaccine to Target IL15, IL15RA and CD80 for Acute Myeloblastic Leukemia

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) University of California San Francisco

Preclinical

Glioblastoma Multiforme (GBM) Wayshine Biopharma Inc

Preclinical

Glioblastoma Multiforme (GBM) Wayshine Biopharma Inc

Preclinical

Hematological Tumor$XBIO Xenetic Biosciences, Inc.

Preclinical

Metastatic Ovarian Cancer Nami Therapeutics Corp

Preclinical

Pancreatic Ductal Adenocarcinoma Excellamol Inc

Preclinical

High-Grade Glioma Excellamol Inc

Preclinical

Non-Small Cell Lung Cancer$XLO Xilio Therapeutics, Inc.

Preclinical

Triple-Negative Breast Cancer (TNBC) Xyone Therapeutics Inc

Preclinical

Pancreatic Ductal Adenocarcinoma Xyone Therapeutics Inc

Preclinical

Hepatocellular Carcinoma Ymmunobio AG

Preclinical

Gastric Cancer$ZLAB Zai Lab Ltd

Preclinical

afatinib + palbociclib

afatinib [INN] + palbociclib

Chordoma Collaborations Pharmaceuticals Inc

Preclinical

apomorphine palmitate

Apomorphine palmitate

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Leukos Biotech SL

Preclinical

bendamustine [INN]

Chronic Lymphocytic Leukemia (CLL) Exinda Therapeutics LLC

Preclinical

Pancreatic Ductal Adenocarcinoma Hebrew University of Jerusalem

Preclinical

Radiodermatitis BioCurity Pharmaceuticals Inc